Related Experiment Video
Updated: Apr 18, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
PmrD is required for modifications to escherichia coli endotoxin that promote antimicrobial resistance
Erica J Rubin1, Carmen M Herrera2, Alexander A Crofts2
1Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA.
Abstract:
In Salmonella enterica, PmrD is a connector protein that links the two-component systems PhoP-PhoQ and PmrA-PmrB. While Escherichia coli encodes a PmrD homolog, it is thought to be incapable of connecting PhoPQ and PmrAB in this organism due to functional divergence from the S. enterica protein. However, our laboratory previously observed that low concentrations of Mg(2+), a PhoPQ-activating signal, leads to the induction of PmrAB-dependent lipid A modifications in wild-type E. coli (C. M. Herrera, J. V. Hankins, and M. S. Trent, Mol Microbiol 76:1444-1460, 2010, http://dx.doi.org/10.1111/j.1365-2958.2010.07150.x). These modifications include phosphoethanolamine (pEtN) and 4-amino-4-deoxy-l-arabinose (l-Ara4N), which promote bacterial resistance to cationic antimicrobial peptides (CAMPs) when affixed to lipid A. Here, we demonstrate that pmrD is required for modification of the lipid A domain of E. coli lipopolysaccharide (LPS) under low-Mg(2+) growth conditions. Further, RNA sequencing shows that E. coli pmrD influences the expression of pmrA and its downstream targets, including genes coding for the modification enzymes that transfer pEtN and l-Ara4N to the lipid A molecule. In line with these findings, a pmrD mutant is dramatically impaired in survival compared with the wild-type strain when exposed to the CAMP polymyxin B. Notably, we also reveal the presence of an unknown factor or system capable of activating pmrD to promote lipid A modification in the absence of the PhoPQ system. These results illuminate a more complex network of protein interactions surrounding activation of PhoPQ and PmrAB in E. coli than previously understood.
Insights
The Escherichia coli PmrD protein is essential for modifying lipid A, enhancing resistance to antimicrobial peptides. This study reveals PmrD
Area of Science:
- Microbiology
- Molecular Biology
- Bacterial Pathogenesis
Background:
- PmrD in Salmonella enterica links PhoP-PhoQ and PmrA-PmrB two-component systems.
- An Escherichia coli PmrD homolog was previously thought incapable of linking these systems.
- Low Mg(2+) induces PmrA-PmrB-dependent lipid A modifications in E. coli, conferring resistance to cationic antimicrobial peptides (CAMPs).
Purpose of the Study:
- To investigate the role of pmrD in E. coli lipid A modification under low Mg(2+) conditions.
- To elucidate the regulatory network involving PhoPQ, PmrAB, and PmrD in E. coli.
Main Methods:
- Phenotypic analysis of E. coli pmrD mutants.
- RNA sequencing to assess gene expression changes.
- Bacterial survival assays against polymyxin B.
Main Results:
- pmrD is required for E. coli lipid A modification with phosphoethanolamine (pEtN) and 4-amino-4-deoxy-l-arabinose (l-Ara4N) under low Mg(2+).
- E. coli pmrD influences the expression of pmrA and genes encoding lipid A modification enzymes.
- A pmrD mutant exhibits significantly reduced survival against polymyxin B compared to wild-type E. coli.
- An unknown factor activates pmrD independently of the PhoPQ system.
Conclusions:
- E. coli PmrD plays a crucial role in lipid A modification and CAMP resistance.
- The PhoPQ-PmrAB regulatory network in E. coli is more complex than previously understood, involving PmrD.
- The discovery of a PhoPQ-independent activation pathway for PmrD opens new avenues for research.
More Related Videos
07:25High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence
Published on: February 23, 2021
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Bacterial Gastroenteritis
Antibiotic Selection
Stringent Response in E. coli